Bluejay Diagnostics (BJDX) Depreciation and Depletion (2022 - 2026)
Bluejay Diagnostics (BJDX) reported Depreciation and Depletion of $27763.0 for Q1 2026, up 50.88% on a YoY basis from $18401.0 in Q1 2025, and up 1.27% sequentially from $27415.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Depreciation and Depletion (2022 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 5 years of Depreciation and Depletion data on file, last reported at $27763.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 50.88% year-over-year to $27763.0; the trailing twelve-month figure through Mar 2026 stood at $83544.0 (up 12.43% YoY), and the FY2025 full-year result was $74182.0, down 1.9% from the prior year.
- Depreciation and Depletion grew to $27763.0 in Q1 2026, from $27415.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $253175.0 in Q2 2023 to a low of $10624.0 in Q3 2025.
- A 5-year average of $57815.8 and a median of $27415.0 in 2025 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion surged 501.02% in 2023 and sank 93.02% in 2024, its largest moves.
- Tracing BJDX's Depreciation and Depletion over 5 years: stood at $30682.0 in 2022, then decreased by 27.18% to $22342.0 in 2023, then fell by 11.49% to $19775.0 in 2024, then surged by 38.63% to $27415.0 in 2025, then rose by 1.27% to $27763.0 in 2026.
- Business Quant data shows BJDX's Depreciation and Depletion at $27763.0 in Q1 2026, $27415.0 in Q4 2025, and $10624.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 27,763.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,763.00 |
| Mar 31, 2026 | 27,763.00 |
| Dec 31, 2025 | 27,415.00 |
| Dec 31, 2025 | 27,415.00 |
| Sep 30, 2025 | 10,624.00 |
| Sep 30, 2025 | 10,624.00 |
| Jun 30, 2025 | 17,742.00 |
| Jun 30, 2025 | 17,742.00 |
| Mar 31, 2025 | 18,401.00 |
| Mar 31, 2025 | 18,401.00 |
| Dec 31, 2024 | 19,775.00 |
| Dec 31, 2024 | 19,775.00 |
| Sep 30, 2024 | 17,665.00 |
| Sep 30, 2024 | 17,665.00 |
| Jun 30, 2024 | 18,464.00 |
| Jun 30, 2024 | 18,464.00 |
| Mar 31, 2024 | 19,714.00 |
| Mar 31, 2024 | 19,714.00 |
| Dec 31, 2023 | 22,342.00 |
| Dec 31, 2023 | 22,342.00 |